I am an Associate Professor of Medicine in the Karsh Division of Gastroenterology and Hepatology and serve as Medical Director of the Liver Cancer Program at Cedars-Sinai Cancer. My research focuses on clinical and translational studies in liver cancer, with particular expertise in liver cirrhosis epidemiology, risk stratification, surveillance, early cancer detection, diagnosis, and treatment.

Wendy Spearman: MBChB, MMed, PhD, FCP(SA), FRCP (London)

Wendy Spearman is Emeritus Professor of Medicine and a Consultant Hepatologist in the Division of Hepatology, Department of Medicine, Faculty of Health Sciences at the University of Cape Town. She was appointed as a University of Cape Town Senior Research Scholar in July 2024.
She was Head of the Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town and Head of Liver Transplantation, Groote Schuur Hospital, Cape Town, South Africa from 1/01/1998 - 30/06/2024.

Jennifer Onwochei, MD, is a transplant hepatologist and Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at Northwell Health. Her clinical and academic interests include liver transplantation, community health, global outreach, and medical education. Dr. Onwochei is committed to advancing equitable liver care through patient-centered practice, mentorship, and community engagement.

Mohamed El-Kassas, MD, is Professor and Head of Endemic Medicine and HepatoGastroenterology at the Faculty of Medicine, Capital University, Cairo, Egypt. He is President of the Steatotic Liver Diseases Study Foundation in Middle East and North Africa and serves on several international liver disease committees, including IASL, WGO, AHPBCC, and the Global NASH Council.

Dr. Vos is a Professor of Pediatrics and Associate Chair of Translational Research in the Department of Pediatrics at Michigan State University, as well as the Director of Research for Helen DeVos Children's Hospital at Corewell Health. She has investigated MASLD in children for more than 20 years, contributing to improved dietary strategies and advancing the understanding of emerging therapies and biomarkers. She has authored over 150 peer‑reviewed publications on MASLD and related topics and has maintained continuous NIH funding since 2007. Dr.

Dr. Ruby Mehta is a physician at the U.S. Food and Drug Administration (FDA), where she has served for 12.5 years as a medical officer, Lead Physician, and now as Acting Associate Director for Therapeutic Review in the Division of Hepatology and Nutrition. She is board-certified in Pediatrics, Pediatric Gastroenterology, and Pediatric Transplant Hepatology, and completed her fellowship training at the Children's Hospital of Michigan and Children's Healthcare of Atlanta at Emory University. At the FDA, Dr.

Rohit Kohli MBBS, MS                                                           

MBBS-Armed Forces Medical College, University of Pune, India- 1993-1999

MS in Clinical Investigation, School of Public Health, Northwestern University, Chicago, IL- 2004-2006



Current Academic of Administrative Position:

Professor of Pediatrics (Clinical Scholar) University of Southern California,

Chief, Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital Los Angeles

Prof. Josep M. Llovet is a full professor of Medicine at Hospital Clínic–University of Barcelona and at Mount Sinai Hospital, New York, where he is the Director of the Liver Cancer Program. He has published approximately 400 papers, with an h-index of 150 and more than 140,000 citations, primarily in the field of liver cancer.

Dr. Vodkin is a transplant hepatologist at the University of California, San Diego. She is a dedicated educator across the Department of Medicine, and the program director for the transplant hepatology fellowship. Her clinical and research interests are in Fontan Associated Liver Disease, collaborating with a multidisciplinary team to look at nodule imaging and follow up, clinical management and combined heart-liver transplant.